The death of the patients was not significantly associated with the sex, body weight, SBP, DBP, anti-PF4/heparin antibody, hemoglobin, platelet count and thrombocytopenia, serum creatinine, albumin, bleeding events within the past three months, thromboembolic events within the past three months, dialysis duration in months, number of weekly dialyses (≥3), dialyzer, anticoagulant, and Kt/v (P>0.05). This evidence concerns the gene ALB and Thrombocytopenia.